Possible Prediction of Chemoradiosensitivity of Esophageal Cancer by Serum Protein Profiling
暂无分享,去创建一个
Tomoko Umaki | Tatsuya Aoki | Setsuo Hirohashi | Tesshi Yamada | S. Hirohashi | T. Aoki | K. Honda | A. Tsuchida | Akihiko Tsuchida | Kazufumi Honda | Yasuharu Hayashida | Yoshiaki Osaka | Tomohiko Hara | Y. Hayashida | Tomoko Umaki | T. Hara | Y. Osaka | T. Yamada
[1] K. Kozak,et al. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[2] E. Petricoin,et al. Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.
[3] T. Aoki,et al. Effectiveness of Preoperative Chemoradiotherapy for Advanced Esophageal Carcinoma , 2004 .
[4] Mark S. Boguski,et al. Biomedical informatics for proteomics , 2003, Nature.
[5] Gisbert Schneider,et al. Support vector machine applications in bioinformatics. , 2003, Applied bioinformatics.
[6] D. Chan,et al. Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry , 2004, Clinical Cancer Research.
[7] T. Walsh,et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.
[8] Thomas P Conrads,et al. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. , 2002, Biochemical and biophysical research communications.
[9] Jeffrey S. Morris,et al. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments , 2004, Bioinform..
[10] Tomoko Umaki,et al. Possible detection of pancreatic cancer by plasma protein profiling. , 2005, Cancer research.
[11] P. Schellhammer,et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. , 2002, Cancer research.
[12] Diane Gershon. proteomics technologies: Probing the proteome , 2003, Nature.
[13] W. Mendenhall,et al. Downstaging of Esophageal Cancer After Preoperative Radiation and Chemotherapy , 1995, Annals of surgery.
[14] T. Aoki,et al. Concurrent preoperative chemoradiotherapy for stage III or IV esophageal squamous carcinoma. , 2004, Oncology reports.
[15] A. Venturi,et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis , 2004, Gut.
[16] V. Chiarion Sileni,et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma , 2001, Cancer.
[17] R D Appel,et al. Improving protein identification from peptide mass fingerprinting through a parameterized multi‐level scoring algorithm and an optimized peak detection , 1999, Electrophoresis.
[18] Yu Shyr,et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer , 2003, The Lancet.
[19] R. Hatlevoll,et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer , 1992, World Journal of Surgery.
[20] F. Marshall. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. , 2005, The Journal of urology.
[21] Japanese Society for Esophageal Diseases. Guide lines for the clinical and pathologic studies for carcinoma of the esophagus , 2006, The Japanese journal of surgery.
[22] H. Matsubara,et al. Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma , 2002, British Journal of Cancer.
[23] E. Petricoin,et al. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. , 2004, Current opinion in biotechnology.
[24] R. Bast,et al. Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer , 2004, Cancer Research.
[25] M. Deeg,et al. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients , 2004, Laboratory Investigation.
[26] M. Ferrari,et al. Clinical proteomics: Written in blood , 2003, Nature.
[27] M. Talamini,et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.